Bodybuilding ForumYour AmSpace Profile
Register Forum AmSpaceStore Rules Search Today's Posts Mark Forums Read
Join Anabolicminds.com!! Register Today!
 
  AnabolicMinds.com Forum > Anabolic Discussion > Post Cycle Therapy
 
LinkBack Thread Tools    Search this Thread     
Old 05-30-2006, 03:57 AM   #1
Registered User
 
ArnoldIsMyIdol's Avatar
 
Join Date: Apr 2006
Posts: 367
Leave Comment
Reputation: 94 ArnoldIsMyIdol will become famous soon enough
Points: 1,862, Level: 17Points: 1,862, Level: 17Points: 1,862, Level: 17
Level up: 18%, 88 Points neededLevel up: 18%, 88 Points neededLevel up: 18%, 88 Points needed
Activity: 0%Activity: 0%Activity: 0%

View Profile
Study of Nolva side effects in men

Cancer. 1994 Jul 1;74(1):74-7. Related Articles, Links tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.

Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

BACKGROUND. Although an uncommon disease, male breast cancer (MBC) will be responsible for 300 deaths in 1993 in the United States. Because of the high rate of estrogen receptor positivity in males, adjuvant hormonal therapy with tamoxifen in the adjuvant setting has been used widely. Little is known about the side effects of this estrogen receptor blocker in males. METHODS. The authors evaluated the side effects of adjuvant tamoxifen treatment in 24 patients (19 of whom were estrogen receptor positive) treated at the authors' institution between 1990 and 1993. RESULTS. Fifteen (62.5%) patients reported at least one side effect. The most common side effect was a decrease in libido, which occurred in 7 (29.2%) patients; followed by weight gain, which occurred in 6 (25%) patients; hot flashes, which occurred in 5 (20.8%); mood alterations, which occurred in 5 (20.8%); depression, which occurred in 4 (16.6%); insomnia, which occurred in 3 (12.5%); and deep venous thrombosis, which occurred in 1 (4.2%). Five (20.8%) patients terminated treatment with tamoxifen in less than 1 year because of these side effects. Two of these patients had decreased libido, two had hot flashes, and one suffered deep venous thrombosis. CONCLUSIONS. In contrast to female breast cancer patients, who have a 4% attrition rate to adjuvant tamoxifen treatment, MBC patients have a 20.8% attrition rate related to side effects of tamoxifen treatment
__________________
 
ArnoldIsMyIdol is offline   Reply With Quote
Old 05-30-2006, 09:17 AM   #2
Moderator
Board Moderator
 
size's Avatar
 
Join Date: Jan 2003
Age: 36
Posts: 4,237
Leave Comment
Reputation: 162 size has a spectacular aura about
Points: 6,869, Level: 35Points: 6,869, Level: 35Points: 6,869, Level: 35
Level up: 36%, 181 Points neededLevel up: 36%, 181 Points neededLevel up: 36%, 181 Points needed
Activity: 0%Activity: 0%Activity: 0%

View Profile
This would be more helpful if we knew the dosages and timelines. 19 patients took nolvadex for over 1 year, and obviously, this is something that would be very uncommon for an AAS user.
 



size is a fictitious character.

Respect yourself and others will respect you.
size is offline   Reply With Quote
Old 06-07-2006, 01:58 PM   #3
Registered User
 
flex167's Avatar
 
Join Date: Apr 2006
Posts: 15
Leave Comment
Reputation: 10 flex167 is on a distinguished road
Points: 213, Level: 4Points: 213, Level: 4Points: 213, Level: 4
Level up: 5%, 37 Points neededLevel up: 5%, 37 Points neededLevel up: 5%, 37 Points needed
Activity: 0%Activity: 0%Activity: 0%

View Profile
These side effects would seem obvious since nolva is in essence a type of estrogen and when estrogen levels arent what they normally were there are bound to be some side effects to go along with it
 
flex167 is offline   Reply With Quote
Reply



Thread Tools Search this Thread
Search this Thread:

Advanced Search



All times are GMT -5. The time now is 09:28 PM.



Powered by vBulletin® Version 3.6.10
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO 3.1.0 ©2007, Crawlability, Inc.
Copyright
2002 - 2008 Anabolicminds.com